Welcome to Lamellar Biomedical
Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. Diseases which may benefit from the application of mimetic Lamellar bodies include Dry Mouth, Dry Eye and Cystic Fibrosis. All these conditions are poorly served by current medications and represent areas of high value unmet medical need.
Learn moreResearch & Development
Lamellar in partnership with clinical centres-of-excellence is highly advanced in developing novel products for Dry Mouth, Dry Eye and Cystic Fibrosis.
Learn moreInvestors
Lamellar Biomedical Shareholders comprise both institutional and private investors.
Learn more
Lamellar Biomedical
A privately held, innovative, biotechnology company bringing new patent protected medical products to the healthcare market.
Strategic Goals
To develop Lamellar technology to address areas of high medical cost and unmet medical need.
Product pipeline
Lamellar's patented technology covers an extensive range of therapeutic areas.